2.70
8.47%
-0.25
Dopo l'orario di chiusura:
2.70
Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
41.47%
4.743
|
3.3527 | 2.4905 | 1.2217 | 1.2541 |
Interest Income/Expense |
100.00%
-
|
-0.000161 | - | 0.2218 | 0.0834 |
Operating Income/Loss |
41.47%
-4.743
|
-3.3527 | -2.4905 | -1.2217 | -1.2541 |
Income/Loss From Continuing Operations Before Tax |
45.15%
-4.603
|
-3.1712 | -2.3297 | -3.7005 | -1.3365 |
Income/Loss From Continuing Operations After Tax |
45.15%
-4.603
|
-3.1712 | -2.3297 | -3.7005 | -1.3365 |
Net Income/Loss
|
45.15%
-4.603
|
-3.1712 | -2.3297 | -3.7005 | -1.3365 |
Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
-1.3235 | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
698.76%
13.71
|
1.7163 | 13.66 | 3.5166 | -0.0529 |
Diluted Average Shares |
698.76%
13.71
|
1.7163 | 13.66 | 3.5166 | -0.0529 |
Basic Earnings Per Share |
183.33%
-0.34
|
-0.12 | -0.17 | -1.05 | -0.40 |
Diluted Earnings Per Share |
183.33%
-0.34
|
-0.12 | -0.17 | -1.05 | -0.40 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
-1.3235 | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):